drugset / Trial / NCT00575341

Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency

NCT00575341

Phase 3 Completed 23 enrolled University Hospital Tuebingen
RandomizedParallel-groupTriple-blindTreatment

Summary

30 adolescent girls and young women between 13 and 26 years with central adrenal insufficiency and a grand shortage of DHEA are recruit. The clinical trial is double-blind to show that the substitution of the hormone DHEA stimulates secondary hair growth, enhances well being and mood of the patients. It should also normalize the serum content of DHEA, aldosterone and testosterone.

Timeline

Start
2003-10
Primary completion
Completion
2007-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dehydroepiandrosterone Other / unclassified 25 mg Oral